The World Health Organization said Friday that Zika vaccines could be at least 18 months away from broad trials, according to ABC News.
Dr. Marie-Paule Kieny, WHO assistant director-general for Health Systems and Innovation, made the announcement during a press conference in Geneva, Switzerland, said ABC News. She also said two organizations seem to be more advanced: a DNA vaccine from the U.S. National Institutes for Health and an inactivated product from Bharat Biotech in India, said ABC News.
To date, 10 companies can provide tests to detect the virus. Nucleic acid tests are based on a molecular technique used to detect a virus in the blood while serological tests measure the levels of antibodies as a result of exposure to a particular virus, said ABC News. Another 10 companies are in the process of vaccine development, added ABC News.
Click here to sign up for Daily Voice's free daily emails and news alerts.